Elevated levels of circulating cell-free DNA in the blood of patients with hepatitis C virus-associated hepatocellular carcinoma

Anticancer Research

Volumn 26, Issue 6 C, 2006, Pages 4713-4719

  Iizuka, Norio ^a   Sakaida, Isao ^a   Moribe, Toyoki ^b   Fujita, Nozomi ^b   Miura, Toshiaki ^b   Stark, Markus ^b   Tamatsukuri, Shigeru ^b   Ishitsuka, Hideo ^b   Uchida, Koichi ^a   Terai, Shuji ^a   Sakamoto, Kazuhiko ^a   Tamesa, Takao ^a   Oka, Masaaki ^a,c  

^a YAMAGUCHI UNIVERSITY   (Japan)

^b Molecular Diagnostics Division   (Japan)

^c YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Blood testing; Cell free DNA; GSTP1; HCC; HCV; Real time PCR

Indexed keywords

ALPHA FETOPROTEIN; BIOLOGICAL MARKER; DECARBOXYPROTHROMBIN; DNA; GLUTATHIONE TRANSFERASE P1;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CELL FREE SYSTEM; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; DNA EXTRACTION; FEMALE; GENETIC ANALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HETEROZYGOTE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR DIFFERENTIATION; TUMOR VOLUME;

AGED; CARCINOMA, HEPATOCELLULAR; DNA, NEOPLASM; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 33845944975     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Estimating the world cancer burden: Globocan 2000. Int J Cancer 94: 153-156, 2001.
2. Llovet JM, Burroughs A and Bruix J: Hepatocellular carcinoma. Lancet 362: 1907-1917, 2003.
3. Poynard T, Yuen MF, Ratziu V and Lai CL: Viral hepatitis C. Lancet 362: 2095-2100, 2003.
4. Iizuka N, Oka M, Yamada-Okabe H, Nishida M, Maeda Y, Mori N, Takao T, Tamesa T, Tangoku A, Tabuchi H, Hamada K, Nakayama H, Ishitsuka H, Miyamoto T, Hirabayashi A, Uchimura S and Hamamoto Y: Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection. Lancet 361: 923-929, 2003.
5. Marrero JA and Lok AS: Newer markers for hepatocellular carcinoma. Gastroenterology 127: S113-S119, 2004.
6. Hu KQ, Kyulo NL, Lim N, Elhazin B, Hillebrand DJ and Bock T: Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma. Am J Gastroenterol 99: 860-865, 2004.
7. Gupta S, Bent S and Kohlwes J: Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis. Ann Intern Med 139: 46-50, 2003.
8. Leon SA, Green A, Yaros MJ and Shapiro B: Radioimmunoassay for nanogram quantities of DNA. J Immunol Methods 9: 157-164, 1975.
9. Wu TL, Zhang D, Chia JH, Tsao KH, Sun CF and Wu JT: Cell-free DNA: measurement in various carcinomas and establishment of normal reference range. Clin Chim Acta 321: 77-87, 2002.
10. Ren N, Qin LX, Tu H, Liu YK, Zhang BH and Tang ZY: The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma. J Cancer Res Clin Oncol 132: 399-407, 2006.
11. Yamasaki T, Kimura T, Kurokawa F, Aoyama K, Ishikawa T, Tajima K, Yokoyama Y, Takami T, Omori K, Kawaguchi K, Tsuchiya M, Terai S, Sakaida I and Okita K: Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy. J Gastroenterol 40: 70-78, 2005.
12. Shirahashi H, Sakaida I, Terai S, Hironaka K, Kusano N and Okita K: Ubiquitin is a possible new predictive marker for the recurrence of human hepatocellular carcinoma. Liver 22: 413-418, 2002.
13. Sobin LH and Wittekind C: TNM Classification of Malignant Tumours, 6th ed., UICC, Wiley-Liss, pp. 81-83, 2002.
14. Monroe JJ, Manjanatha MG and Skopek TR: Extent of CpG methylation is not proportional to the in vivo spontaneous mutation frequency at transgenic loci in Big Blue™ rodents. Mutat Res 476: 1-11, 2001.
15. Tost J, Schatz P, Schuster M, Berlin K and Gut IG: Analysis and accurate quantification of CpG methylation by MALDI mass spectrometry. Nucleic Acids Res 31: e50, 2003.
16. Tetzner R and Distler J: Improved heavymethyl assay for the methylation analysis of the GSTP1 gene. International Publication Number WO 2004/113567: 24-25, 2004.
17. Fattovich G, Stroffolini T, Zagni I and Donato F: Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127: S35-S50, 2004.
18. Ziegler A, Zangemeister-Wittke U and Stahel RA: Circulating DNA: a new diagnostic gold mine? Cancer Treat Rev 28: 255-271, 2002.
19. Fournie GJ, Bret L and Belenguer P: Physicochemical characterization of plasma DNA. Lupus 1: 186, 1992.
20. Savill J, Fadock V, Hensons P and Haslett C: Phagocyte recognition of cells undergoing apoptosis. Immunol Today 14: 131-136, 1993.
21. Fournie GJ, Courtin JP, Laval F, Chale JJ, Pourrat JP, Pujazon MC, Lauque D and Carles P: Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. Cancer Lett 91: 221-227, 1995.
22. Chen XQ, Bonnefoi H, Pelte MF, Lyautey J, Lederrey C, Movarekhi S, Schaeffer P, Mulcahy HE, Meyer P, Stroun M and Anker P: Detecting tumour-related alterations in plasma or serum DNA of patients diagnosed with breast cancer. Clin Cancer Res 5: 2297-2303, 1999.
23. Lee TH, Montalvo L, Chrebtow V and Busch MP: Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma. Transfusion 41: 276-282, 2001.
24. Lui YY, Chik KW, Chiu RW, Ho CY, Lam CW and Lo YM: Predominant haematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin Chem 48: 421-427, 2002.
25. Rogers JG, Boldt D, Kornfeld S, Skinner A and Valeri CR: Excretion of deoxyribonucleic acid by lymphocytes stimulated with phytohaemagglutinin or antigen. Proc Natl Acad Sci USA 69: 1685-1689, 1972.
26. Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD and Knippers R: DNA fragments in the blood plasma of cancer patients: quantitation and evidence for their origin from apoptotic and necrotic cells. Cancer Res 61: 1659-1665, 2001.
27. Iizuka N, Oka M, Yamada-Okabe H, Mori N, Tamesa T, Okada T, Takemoto N, Tangoku A, Hamada K, Nakayama H, Miyamoto T, Uchimura S and Hamamoto Y: Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data based on a supervised learning method. Cancer Res 62: 3939-3944, 2002.
28. Iizuka N, Oka M, Yamada-Okabe H, Mori N, Tamesa T, Okada T, Takemoto N, Sakamoto K, Hamada K, Ishitsuka H, Miyamoto T, Uchimura S and Hamamoto Y: Self-organizing-map-based molecular signature representing the development of hepatocellular carcinoma. FEBS lett 579: 1089-1100, 2005.